NCT06609434 2024-09-27
The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer
Peking University Cancer Hospital & Institute
Phase NA Not yet recruiting
Clinical Trials
9 trialsNCT00004142 2018-10-26
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03686254 2018-09-26
The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM
Nanfang Hospital, Southern Medical University
Phase 2/3 Unknown
NCT00408772 2017-06-09
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
University of California, Davis
Phase 2 Withdrawn
NCT00030563 2017-04-17
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
University of Washington
Phase 2 Completed
NCT01867918 2017-01-09
LOTCOL
Oslo University Hospital
Phase NA Terminated
NCT00043004 2012-09-24
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT00499395 2012-04-03
Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT00899210 2011-05-17
Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer
National Cancer Institute (NCI)
Completed